The EPA has rejected a petition from the trade group CropLife America to delay the implementation of its Endocrine Disruptor Screening Program, which is designed to identify chemicals that could disrupt the endocrine system. The group asked the EPA to further analyze the cost of the program and explain why existing data are not sufficient.

Full Story:

Related Summaries